In a large randomized trial of adolescent girls, one dose of either the bivalent or nonavalent human papillomavirus (HPV) ...

A latest study has brought about a ground breaking discovery.Eradicating cervical cancer may require vaccinating against the ...

The vaccine works best when the series is started early (around ages 11 or 12) but in 2018, the FDA expanded its approval to include adults up to age 45, showing that it can still provide protection ...

Human papillomavirus (HPV) vaccines have long been central to reducing the global incidence of HPV‐associated cancers and benign lesions. Traditional vaccines, based on virus‐like particles (VLPs) ...

USA: A major international clinical trial published in the New England Journal of Medicine has delivered encouraging evidence ...

Although human papillomavirus (HPV) vaccines are best known for preventing cervical cancer, a new study from Sweden finds that women and girls who received the immunizations are also less likely to ...

Standard human papillomavirus (HPV) vaccination reduced actinic keratosis (AK) burden in immunocompetent individuals with multiple lesions, with effects observed in both the total number of lesions ...

Discover if the HPV vaccine is still an option for you as an adult. Learn about eligibility, vaccination benefits, and how to make an informed decision with your doctor.

DECADES of virology research that yielded the human papillomavirus (HPV) vaccine and identified the virus as a primary cause ...

We do not have to be losing 350,000 people globally to cervical cancer each year,” said study senior author Abba Gumel.